YB‐1 protein: functions and regulation

DN Lyabin, IA Eliseeva… - Wiley Interdisciplinary …, 2014 - Wiley Online Library
The Y‐box binding protein 1 (YB‐1, YBX1) is a member of the family of DNA‐and RNA‐
binding proteins with an evolutionarily ancient and conserved cold shock domain. It falls into …

Y-box-binding protein 1 (YB-1) and its functions

IA Eliseeva, ER Kim, SG Guryanov… - Biochemistry …, 2011 - Springer
This review describes the structure and functions of Y-box binding protein 1 (YB-1) and its
homologs. Interactions of YB-1 with DNA, mRNAs, and proteins are considered. Data on the …

YB-1: oncoprotein, prognostic marker and therapeutic target?

A Lasham, CG Print, AG Woolley, SE Dunn… - Biochemical …, 2013 - portlandpress.com
Hanahan and Weinberg have proposed the 'hallmarks of cancer'to cover the biological
changes required for the development and persistence of tumours [Hanahan and Weinberg …

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells

BW Sutherland, J Kucab, J Wu, C Lee, MCU Cheang… - Oncogene, 2005 - nature.com
Akt/PKB is a serine/threonine kinase that promotes tumor cell growth by phosphorylating
transcription factors and cell cycle proteins. There is particular interest in finding tumor …

The common and distinct target genes of the p53 family transcription factors

K Harms, S Nozell, X Chen - Cellular and Molecular Life Sciences CMLS, 2004 - Springer
Abstract p53 is the most commonly mutated gene in human cancer. After activation by
cellular stresses such as DNA damage or oncogene activation, p53, a sequence-specific …

[HTML][HTML] YB-1 as an oncoprotein: functions, regulation, post-translational modifications, and targeted therapy

Q Yin, M Zheng, Q Luo, D Jiang, H Zhang, C Chen - Cells, 2022 - mdpi.com
Y box binding protein 1 (YB-1) is a protein with a highly conserved cold shock domain (CSD)
that also belongs to the family of DNA-and RNA-binding proteins. YB-1 is present in both the …

[HTML][HTML] Targeting lipid metabolism in the treatment of ovarian cancer

S Chaudhry, SN Thomas, GE Simmons Jr - Oncotarget, 2022 - ncbi.nlm.nih.gov
Cancer cells undergo alterations in lipid metabolism to support their high energy needs,
tumorigenesis and evade an anti-tumor immune response. Alterations in fatty acid …

[图书][B] Liberation biology: The scientific and moral case for the biotech revolution

R Bailey - 2013 - books.google.com
The 21st century will undoubtedly witness unprecedented advances in understanding the
mechanisms of the human body and in developing biotechnology. With the mapping of the …

The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma

M Chatterjee, C Rancso, T Stühmer… - Blood, The Journal …, 2008 - ashpublications.org
Current knowledge about molecular mechanisms underlying disease progression and drug
resistance in multiple myeloma (MM) is still limited. Here, we analyzed the potential …

Transcription factors that interact with p53 and M dm2

K Inoue, EA Fry, DP Frazier - International journal of cancer, 2016 - Wiley Online Library
The tumor suppressor p53 is activated upon cellular stresses such as DNA damage,
oncogene activation, hypoxia, which transactivates sets of genes that induce DNA repair …